Mycoplasma hominis

A positive urine result here means one specific bacterium was found in your sample. What it means for your health depends heavily on context, because this organism lives quietly in many healthy people yet occasionally drives real infection.

The value of testing is not a simple yes-or-no verdict. It is a piece of information that becomes meaningful only when you weigh it against your symptoms, your reproductive plans, and your immune status.

What This Bacterium Is

M. hominis (Mycoplasma hominis) is one of the smallest self-copying organisms known. It belongs to a group of bacteria (called the Mollicutes) that lack an outer cell wall, the rigid shell most bacteria carry.

That missing cell wall matters in a practical way. Many common antibiotics, including penicillins and cephalosporins, work by attacking the cell wall, so they have no effect on this organism. It commonly colonizes the lower urinary and genital tract of sexually active adults, which is why finding it does not automatically signal disease.

Colonization Versus Infection

The single most important thing to understand is that detection often reflects harmless carriage rather than active infection. In one Japanese study, urine testing found this bacterium in 7.0% of women and 2.9% of men, most of whom had no disease from it.

It is rarely the sole troublemaker. In a large surveillance study from Eastern China, pure infection with this organism alone was uncommon at 0.66%, while it showed up alongside a related bacterium (Ureaplasma) far more often, at 6.08%.

Urine also tends to carry a lighter load of the organism than a genital swab does. In one sexual health cohort, 93% of urine-positive samples fell below a defined concentration threshold, while swabs more often exceeded it. This means a urine positive is best read as a signal to interpret, not a diagnosis to act on blindly.

Pregnancy and Preterm Birth

The pregnancy signal is real but unsettled. Some pooled analyses link this bacterium to preterm birth, with one review finding roughly 87% higher odds (odds ratio 1.87) and another finding about 2.25 times the odds compared with women without it. A 2026 meta-analysis found a smaller but still elevated risk (adjusted odds ratio about 1.75) when the organism was detected in cervicovaginal samples specifically. But other studies disagree: one large meta-analysis found no significant link to preterm birth, and a prospective cohort found none either, so the evidence is genuinely mixed.

Those reviews are careful to say the evidence cannot prove cause. Most studies did not account for other factors, and the organism travels so often with bacterial vaginosis (a shift in the normal vaginal bacteria) that separating their effects is difficult. The risk also appears stronger when the organism is found in fetal tissues such as amniotic fluid or placenta than when it is only found in cervicovaginal samples. If you are pregnant, this is a number to discuss in context, not a reason to panic.

Fertility and Reproductive Health

Detection is consistently more common in people struggling with fertility than in those who are not. A meta-analysis found this organism carried about 56% higher odds of female infertility (odds ratio 1.56), along with sharply higher odds of miscarriage and stillbirth in that dataset. In men, a separate 21-study analysis found about 84% higher odds among infertile men (odds ratio 1.84), though this link was significant mainly in studies from China and was not statistically significant when the data were pooled worldwide.

In men, the organism has been tied to inflammation in semen, with higher levels of inflammatory signaling proteins and more immune cells, alongside measurable drops in sperm quality. This supports genuine biological effect beyond simple presence, which is why it earns a place in a fertility workup rather than routine screening.

Upper Urinary Tract Infection

The clearest urinary disease link is to kidney infection (pyelonephritis), not to lower-tract problems like bladder or urethral irritation. A review of older studies estimated this organism accounts for roughly 5% of acute kidney infection cases, often with no other bacteria found.

One classic diagnostic study found that patients with pure infection from this organism had kidney infection without any lower urinary tract symptoms at all. Antibodies against it appeared in urine only in those with an active kidney attack, which underlines that a routine bladder-urine positive is not enough on its own to prove upper-tract disease.

Invasive Infection in Vulnerable People

The mistake that carries the highest stakes is dismissing this organism as always harmless. In people with weakened immune systems, and especially after surgery or organ transplant, it can spread beyond the genital tract and cause serious infections of the chest, joints, blood, or lining of the abdomen.

These invasive infections are rare but repeatedly reported, and they are dangerous partly because they hide. The organism does not show up on a standard Gram stain and does not respond to the cell-wall antibiotics doctors usually reach for first, so a culture-negative infection can smolder until someone tests for it specifically. Transplant reports have even traced infections back to the donor organ.

Why Routine Tests Miss It

This is the practical reason the test exists. The organism grows slowly, forms tiny pinpoint colonies on ordinary media, and needs special conditions, so a standard urine culture can easily overlook it. Because it lacks a cell wall, it also does not take up the usual Gram stain that flags most bacteria under a microscope.

Molecular testing (which detects the organism's DNA) sidesteps these problems. In one study of pregnant women, culture flagged the organism in only 2 women while DNA testing found it in 8. The test's main job is to catch a fastidious organism that chlamydia and gonorrhea panels, Gram stain, and routine culture were never designed to find.

How Accurate the Test Is

One assay evaluated against a high-sensitivity DNA method (qPCR) caught about 78 out of 100 true cases and correctly cleared about 99 out of 100 people without the organism. In plain terms, a positive result is usually trustworthy, but a negative urine result does not fully rule the organism out.

Specimen choice affects accuracy. In women with lower urinary tract symptoms, a urethral swab identified the organism more accurately than urine did (specificity 99.9% and positive predictive value 99.6% for the swab, versus 96% and 75% for urine). If lower-tract disease is genuinely suspected, a swab is the stronger sample.

When Results Can Be Misleading

• Common carriage: this organism is found in many people with no symptoms, including about 4% of asymptomatic adults in one urine screening study, so a positive can simply mean colonization.
• Frequent coinfection: it travels with Ureaplasma in the great majority of cases (91% of organism-positive women in one study also carried Ureaplasma), which makes it hard to blame symptoms on this organism alone.
• Specimen and load: urine typically carries a lower organism load than a swab, so a urine result can differ from a swab taken the same day, occasionally missing an infection a swab would catch.
• Cell-wall antibiotics: a course of penicillin or a cephalosporin for an unrelated issue will not clear this organism, so persistent detection after such treatment does not mean the drug failed at its intended target.

Why One Reading Is Not Enough

A single positive is a starting point, not a conclusion. Because carriage is common and load fluctuates, the more useful information often comes from retesting in the right context: after treatment to confirm the organism has cleared, or from a better specimen if the clinical picture does not fit.

If you are being treated, retesting after finishing antibiotics can help confirm clearance rather than assuming the drug worked, though there are no established guidelines on the best timing for a test-of-cure with this organism specifically. If you are asymptomatic and simply screening, tracking whether the organism appears and disappears over time is more informative than a single snapshot, especially given how often it comes and goes with sexual exposure.

What to Do With an Unexpected Result

The right next step depends on the pattern, not the isolated positive. If you have genital or urinary symptoms and standard STI testing came back negative, this result helps fill the gap, and pairing it with tests for chlamydia, gonorrhea, trichomonas, and Ureaplasma clarifies whether one organism or a mix is driving things. A urine white blood cell count can show whether there is active inflammation to explain.

In women, checking bacterial vaginosis status matters, because this organism tracks strongly with it and BV may be the real driver of symptoms. If you are in a fertility workup, a positive belongs in a broader reproductive evaluation. And if you are a transplant recipient or immunocompromised and develop an infection that will not clear on standard antibiotics, this result should prompt a conversation with an infectious disease specialist about targeted therapy and susceptibility testing, since resistance is a genuine concern.